Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from sandimmun to neoral

被引：0
|
作者：
Vathsala, A [1 ]
Lee, WT [1 ]
Jacob, E [1 ]
Woo, KT [1 ]
机构：
[1] SINGAPORE GEN HOSP,DEPT BIOCHEM,SINGAPORE 0316,SINGAPORE
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1324 / 1326
页数：3
相关论文
共 50 条
  • [31] Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients
    Beaudreuil, Severine
    Schermann, Jean Michel
    Verstuyft, Celine
    Barrail-Tran, Aurelie
    Smirnova, Maria
    Durrbach, Antoine
    Becquemont, Laurent
    CLINICAL TRANSPLANTATION, 2018, 32 (11)
  • [32] CONVERSION FROM SANDIMMUN TO SANDIMMUN-NEORAL IN PATIENTS WITH STABLE RENAL-ALLOGRAFTS - RESULTS AFTER 1 MONTH
    NEUMAYER, HH
    FARBER, L
    HALLER, P
    KOHNEN, R
    MAIBUCHER, A
    SCHUSTER, A
    VOLLMAR, J
    WAISER, J
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2944 - 2948
  • [33] Conversion from cyclosporine sandimmune to cyclosporine neoral in the stable renal transplant population
    Griffin, PJA
    Moore, RH
    Jurewicz, WA
    Lord, RHH
    Webley, Y
    Jenkins, J
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 303 - 303
  • [34] Safety and efficacy of conversion from once daily Sandimmune to twice daily Neoral cyclosporine in renal allograft recipients
    Vathsala, A
    Lee, WT
    Lu, YM
    Woo, KT
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1746 - 1748
  • [35] Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function
    Konstadinidou, I
    Boletis, JN
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 163S - 166S
  • [36] Efficacy and safety of generic Cyclosporine compared to Sandimmun® Neoral:: An open, controlled clinical trial in stable renal transplants.
    Durlik, M
    Baczkowska, T
    Cieciura, T
    Oldakowska, U
    Rauch, C
    Thyroff, U
    Paczek, L
    TRANSPLANTATION, 2000, 69 (08) : S162 - S162
  • [37] SANDIMMUN NEORAL, A NEW ORAL FORMULATION OF CYCLOSPORINE-A WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS - SAFETY AND TOLERABILITY IN RENAL-TRANSPLANT PATIENTS
    TAESCH, S
    NIESE, D
    MUELLER, EA
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3147 - 3149
  • [38] Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
    Gaston, R
    Alloway, RR
    Gaber, AO
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 326 - 327
  • [39] Cyclosporine Neoral profiling in Japanese renal transplant recipients
    Aikawa, A
    Arai, K
    Tajima, E
    Kawamura, T
    Ogiwara, H
    Sakai, K
    Mizuiri, S
    Ohara, T
    Hasegawa, A
    Kosugi, T
    Kusano, A
    Matsuo, K
    Obayashi, M
    Kurokawa, M
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3142 - 3145
  • [40] Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: Does fat intake still matter?
    Klauser, RM
    Irschik, H
    Kletzmayr, J
    Sturm, I
    Brunner, W
    Woloszczuk, W
    Kovarik, J
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (07) : 3137 - 3140
12345